MERCURY BIOPHARMACEUTICAL CORPORATI financial statements, including revenue, expenses, and profit
The total revenue of 6932 for the last semiannual is 246.00 k TWD, and it's 94.78% lower compared to the previous semiannual. The net income of H2 24 is -32.27 M TWD.